The goal of this webinar is two-fold Educate providers about cannabis, its components and potential implications regarding its use either recreationally or medically Review the literature regarding potential harms/benefits of cannabis in patients with liver disease
Thursday, 1:00pm - Thursday, 2:00pm
Doctors Anna S. Lok and K. Rajender Reddy will join Dr. Jia-Horng Kao and other faculty from Taiwan to host the first TASL-AASLD Joint Symposium as part of the TASL (Taiwan Association for the Study of the Liver) Annual Meeting, December 14-15, 2019 in Taipei.
Saturday, 8:00am - Sunday, 5:00pm
Emerging Topic Conference: Nuclear Receptors as Common Clinical Targets for the Treatment of Cholestatic and Nonalcoholic Fatty Liver Diseases
This conference gathers translational researchers and clinical investigators in cholestatic and/or fatty liver diseases to review preclinical and clinical investigations, and strategize the rapid emergence of novel, efficient therapeutic options.
Friday, 8:00am - Saturday, 11:15am